Jasper Therapeutics, Inc. (JSPR)

NASDAQ: JSPR · Real-Time Price · USD

Compare

1.480

-0.070 (-4.52%)

At close: Jan 30, 2026, 4:00 PM EST

1.510

+0.030 (2.03%)

After-hours: Jan 30, 2026, 6:32 PM EST

Jasper Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	50.9	71.64	86.89	38.25	84.7	19.84
Cash & Short-Term Investments	50.9	71.64	86.89	38.25	84.7	19.84
Cash Growth	-44.98%	-17.55%	127.16%	-54.84%	326.96%	-26.97%
Other Receivables	-	-	0.25	0.91	0.55	0.6
Receivables	-	-	0.25	0.91	0.55	0.6
Prepaid Expenses	1.27	1.57	1.19	1.61	2.29	0.04
Other Current Assets	2.39	2.6	0.62	0.96	0.29	0.2
Total Current Assets	54.56	75.81	88.94	41.73	87.83	20.69
Property, Plant & Equipment	2.34	2.85	4.19	5.45	4.83	2.03
Other Long-Term Assets	0.57	1.24	1.76	1.18	0.99	0.64
Total Assets	57.47	79.9	94.89	48.36	93.65	23.36
Accounts Payable	9.17	4.03	4.15	1.77	3.92	1.42
Accrued Expenses	10.11	9.52	6.94	4.24	2.81	2.05
Current Portion of Leases	1.7	1.09	0.97	0.87	0.51	-
Other Current Liabilities	0.06	0.6	0.32	0.19	0.79	0.55
Total Current Liabilities	21.04	15.24	12.37	7.07	8.02	4.01
Long-Term Leases	-	0.72	1.81	2.79	2.38	1.62
Long-Term Unearned Revenue	2.26	2.26	2.26	2.26	0.6	0.6
Other Long-Term Liabilities	22.59	-	-	0.26	13.14	8.41
Total Liabilities	45.9	18.23	16.45	12.37	24.14	14.65
Common Stock	0	0	0	-	0	0
Additional Paid-In Capital	319.14	302.54	248.04	141.12	136.96	1.68
Retained Earnings	-307.57	-240.87	-169.6	-105.14	-67.45	-36.81
Total Common Equity	11.57	61.67	78.44	35.99	69.52	-35.13
Shareholders' Equity	11.57	61.67	78.44	35.99	69.52	8.71
Total Liabilities & Equity	57.47	79.9	94.89	48.36	93.65	23.36
Total Debt	1.7	1.81	2.79	3.65	2.89	1.62
Net Cash (Debt)	49.2	69.82	84.1	34.6	81.82	18.21
Net Cash Growth	-45.60%	-16.98%	143.07%	-57.71%	349.19%	-32.95%
Net Cash Per Share	3.13	4.79	8.06	9.48	71.81	105.29
Filing Date Shares Outstanding	27.98	15.02	15.06	10.94	4.95	10.16
Total Common Shares Outstanding	27.98	15.02	11.16	4.62	4.95	9.81
Working Capital	33.52	60.57	76.56	34.67	79.81	16.67
Book Value Per Share	0.41	4.11	7.03	7.78	14.04	-3.58
Tangible Book Value	11.57	61.67	78.44	35.99	69.52	-35.13
Tangible Book Value Per Share	0.41	4.11	7.03	7.78	14.04	-3.58
Machinery	2.21	2.88	2.62	2.35	1.92	0.44
Leasehold Improvements	2.71	2.71	2.48	2.48	2.06	0.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q